banner
c-MET inhibitor AZD-6094, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ227

c-MET inhibitor AZD-6094, Purity ≥98%

Synonym: 1313725-88-0; c-MET inhibitor; HMPL-504; HMPL504; HMPL504; AZD-6094; AZD 6094; AZD6094

  • MDL: MFCD28359096
  • CAS Number: 1313725-88-0
  • Compound CID: 68289010
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
AZD-6094, soluble in DMSO and insoluble in ethanol and water, inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis.
Molecular Weight
345.36
Molecular Formula
C17H15N9
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 14 mg/mL (40.53 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
AZD-6094 is used to study c-MET inhibition, particularly in cancer research focused on overcoming therapeutic resistance.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0